NewsEvents

Your Yourlocation: Home > Efficacy of combined inhalation of tiotropium bromide(136310-93-5) and budesonide /formoterol in patients with severe and severe COPD

The study of the combination of tiotropium and budesonide /formoterol powder inhalation in severe, very severe COPD stable period of observation, the study found that the conventional treatment based on the use of tiotropium bromide(136310-93-5) combined with budesonide /formoterol powder inhalation treatment of stable severe, very severe COPD efficacy is worthy of clinical application. The article published on "Henan Medical Research".

The aim of this study was to evaluate the clinical efficacy of tiotropium combined with budesonide /formoterol inhaler inhalation in patients with stable and very severe chronic obstructive pulmonary diseases(COPD).

We retrospectively analyzed the clinical data of 48 stable and severe COPD patients admitted to Wuyang Hospital from Feb. 2013 to Feb. 2014. They were randomly divided into observation group and control group, 24 cases in each group, The control group was treated with tiotropium bromide(136310-93-5) and the observation group was treated with tiotropium combined with budesonide /formoterol powder inhalation. The therapeutic effect of the two groups was observed.

The results showed that the total effective rate was 85.5% in the observation group and 69.1% in the control group after 4 weeks of continuous treatment, the difference was statistically significant (P <0.05).

Address: TEL:0531-82375879 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved